Fangfang Li

机构：Yanbian University, Chinese Academy of Medical Sciences & Peking Union Medical College, The Affiliated Yongchuan Hospital of Chongqing Medical University, Shenzhen Institutes of Advanced Technology, First Affiliated Hospital of Zhengzhou University, Chongqing Medical University · ORCID：0000-0001-5298-5989

发表论文 48 篇 · 总被引 799 次 · h-index 16

代表论文

• Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs (2023 · Radiation Oncology · 被引 17)
• Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1 (2023 · Chemico-Biological Interactions · 被引 17)
• Establishment of a lipid metabolism disorder model in ApoEb mutant zebrafish (2022 · Atherosclerosis · 被引 17)
• HMGB1 regulates autophagy of placental trophoblast through ERK signaling pathway (2024 · Biology of Reproduction · 被引 16)
• Inhibiting mitochondrial excessive fission alleviates the neuronal damage in Parkinson's disease via regulating PGC-1α mediated mitochondrial biogenesis (2025 · Experimental Neurology · 被引 15)
• Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways (2025 · Acta Pharmaceutica Sinica B · 被引 14)